W.R. Berkley Corp’s Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares FLAC Stock Holding History

W.R. Berkley Corp’s Portfolio FLAC Stock Details FLAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,907	Closed	-$149K	–	486
2022 Q3	$149K	Hold	14,907	–	–	0.01%	506
2022 Q2	$147K	Hold	14,907	–	–	0.01%	545
2022 Q1	$147K	Hold	14,907	–	–	0.01%	558
2021 Q4	$145K	Hold	14,907	–	–	0.01%	555
2021 Q3	$145K	Hold	14,907	–	–	0.01%	436
2021 Q2	$145K	Hold	14,907	–	–	0.01%	361
2021 Q1	$148K	Buy	+14,907	New	+$152K	0.02%	314

W.R. Berkley Corp's FLAC Position: Q4 2022 in Review

W.R. Berkley Corp sold out of Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares (FLAC) in Q4 2022, closing a stake of 14,907 shares — an estimated $149K sold.

W.R. Berkley Corp first reported a position in FLAC in Q1 2021 and held it in 7 quarters. The position peaked at $149K in Q3 2022. 0 funds tracked by Wall St. Rank hold FLAC as of Q4 2022.

W.R. Berkley Corp reported no remaining Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position as of Q4 2022 after selling out during the quarter.
W.R. Berkley Corp sold 14,907 Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares shares in Q4 2022, an estimated $149K.
W.R. Berkley Corp first reported a position in Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares in Q1 2021 and held it in 7 quarters.
W.R. Berkley Corp's Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares position peaked at $149K in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares as of Q4 2022.

Based on W.R. Berkley Corp's 13F filing for Q4 2022, filed 14 Feb 2023.